The rapid rise of infectious and resistant organisms has rendered standard antibiotics ineffective for many common conditions - and it's wreaking havoc on both patient safety and the bottom line for hospitals. Technology plays a growing role in the battle against healthcare-acquired infections (HAIs).
To combat the growing risk of healthcare-acquired infections (HAIs), national regulatory initiatives have been upping the ante on an effective response from the healthcare community. Against that backdrop lies an increasingly value-based reimbursement environment, making both the delivery of quality care and improvement in patient outcomes essential to a healthcare organization’s positive financial performance.
